至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Architecture of a minimal signaling pathway explains the T-cell response to a 1 million-fold variation in antigen affinity and dose.

Proc. Natl. Acad. Sci. U.S.A.. 2016; 
LeverMelissa,LimHong-Sheng,KrugerPhilipp,NguyenJohn,TrendelNicola,Abu-ShahEnas,MainiPhilip Kumar,van der MerwePhilip Anton,Dushek
Products/Services Used Details Operation
Peptide Synthesis HLA-A*02:01 heavy chain (residues 1–278) with C-terminal BirA tag and β2 -microglobulin were expressed as inclusion bodies in Escherichia coli, refolded in vitro in the presence of the relevant NY-ESO-1156−165 peptide variants (SI Appendix, Table S1), and purified using size-exclusion chromatography. All peptides were purchased at >95% purity (GenScript). Get A Quote

摘要

T cells must respond differently to antigens of varying affinity presented at different doses. Previous attempts to map peptide MHC (pMHC) affinity onto T-cell responses have produced inconsistent patterns of responses, preventing formulations of canonical models of T-cell signaling. Here, a systematic analysis of T-cell responses to 1 million-fold variations in both pMHC affinity and dose produced bell-shaped dose-response curves and different optimal pMHC affinities at different pMHC doses. Using sequential model rejection/identification algorithms, we identified a unique, minimal model of cellular signaling incorporating kinetic proofreading with limited signaling coupled to an incoherent feed-forwar... More

关键词

T-cell receptor,immunology,pathway architecture,signaling,systems bio